文献速递瓣膜病与结构性心脏病肺血管病与心包/心肌炎

主动脉瓣狭窄中肺动脉高压的患病率及其对结局的影响

Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes.
PubMed 文献 · Heart · 2023-08-11

结果显示肺动脉高压常见,随严重程度增加长期死亡风险逐步升高,死亡风险升高的阈值位于「临界-轻度」肺动脉高压范围。

要点

  • 至少中度主动脉瓣狭窄成人中肺动脉高压常见,仅13.7%无肺动脉高压。
  • eRVSP升高与长期死亡风险逐步增加相关,校正后HR 1.14-2.94。
  • 死亡风险升高的阈值位于eRVSP 35.01-38.00 mm Hg的临界-轻度范围。

核心结论

  • 在至少中度主动脉瓣狭窄成人中肺动脉高压常见,且死亡风险随肺动脉高压严重程度增加而升高。
  • 死亡风险升高的阈值位于「临界-轻度」肺动脉高压范围(eRVSP 35.01-38.00 mm Hg)。

研究设计与样本

  • 回顾性研究,分析澳大利亚国家超声心动图数据库2000至2019年数据。

主要发现

  • 受试者年龄77±13岁,57.4%为女性。
  • 无、临界、轻度、中度和重度肺动脉高压分别占13.7%、33.9%、29.3%、13.1%和10.1%。
  • 随肺动脉高压加重,E:e'比值及左右心房大小增加(p<0.0001)。
  • 校正分析显示长期死亡风险随eRVSP水平升高而逐步增加(HR 1.14-2.94,临界至重度,p<0.0001)。
  • 死亡阈值见于eRVSP第4十分位(35.01-38.00 mm Hg;HR 1.19,95%CI 1.04-1.35),风险递增至第10十分位(HR 2.86,95%CI 2.54-3.21)。

关键数值与推荐

  • eRVSP分级:无<30.00 mm Hg,临界30.00-39.99 mm Hg,轻度40.00-49.99 mm Hg,中度50.00-59.99 mm Hg,重度>60.00 mm Hg。
  • 死亡风险升高的阈值位于eRVSP 35.01-38.00 mm Hg(第4十分位;HR 1.19,95%CI 1.04-1.35)。

临床怎么用

  • 在至少中度主动脉瓣狭窄患者中应关注eRVSP,即使处于临界-轻度范围也可能提示死亡风险升高。

局限性

  • 本研究为回顾性数据库分析,结果需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The significance of pulmonary hypertension (PHT) complicating aortic stenosis (AS) is poorly characterised. In a large cohort of adults with at least moderate AS, we aimed to describe the prevalence and prognostic importance of PHT in such patients. METHODS: In this retrospective study, we analysed the National Echocardiography Database of Australia (data from 2000 to 2019). Adults with an estimated right ventricular systolic pressure (eRVSP), left ventricular ejection fraction (LVEF) >50% and with moderate or greater AS were included (n=14 980). These subjects were then categorised according to their eRVSP. The relationship between PHT severity and mortality outcomes were evaluated (median follow-up of 2.6 years, IQR 1.0-4.6 years). RESULTS: Subjects were aged 77±13 years and 57.4% were female. Overall, 2049 (13.7%), 5085 (33.9%), 4380 (29.3%), 1956 (13.1%) and 1510 (10.1%) patients had no (eRVSP<30.00 mm Hg), borderline (30.00-39.99 mm Hg), mild (40.00-49.99 mm Hg), moderate (50.00-59.99 mm Hg) and severe PHT (>60.00 mm Hg), respectively. An echocardiographic phenotype was evident with worsening PHT, showing rising E:e' ratio and right and left atrial sizes(p<0.0001, for all). Adjusted analyses showed that the risk of long-term mortality progressively rose as eRVSP level increased (HR 1.14-2.94, borderline to severe PHT, p<0.0001 for all). A mortality threshold was identified in the 4th decile of eRVSP categories (35.01-38.00 mm Hg; HR 1.19, 95% CI 1.04 to 1.35), with risk progressively increasing through to the 10th decile (HR 2.86, 95% CI 2.54 to 3.21). CONCLUSIONS: In this large cohort study, we find that PHT is common in ≥moderate AS and mortality increases as PHT becomes more severe. A threshold for higher mortality lies within the range of 'borderline-mild' PHT. TRIAL REGISTRATION NUMBER: ACTRN12617001387314.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ratwatte S, Stewart S, Strange G, et al. Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes. Heart. 2023. PMID: 37012043. doi:10.1136/heartjnl-2022-322184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。